R
Reza Alibakhshi
Researcher at Kermanshah University of Medical Sciences
Publications - 43
Citations - 375
Reza Alibakhshi is an academic researcher from Kermanshah University of Medical Sciences. The author has contributed to research in topics: Gene mutation & Population. The author has an hindex of 9, co-authored 38 publications receiving 304 citations. Previous affiliations of Reza Alibakhshi include Tehran University of Medical Sciences.
Papers
More filters
Journal ArticleDOI
Analysis of the CFTR gene in Iranian cystic fibrosis patients: Identification of eight novel mutations
TL;DR: A comprehensive analysis of the CFTR gene in Iranian CF patients revealed the identification of 37 mutations, the highest detection rate obtained in the Iranian population so far, which will assist in genetic counseling, prenatal diagnosis and future screening of CF in Iran.
Journal ArticleDOI
Paraoxonase Arg 192 allele is an independent risk factor for three-vessel stenosis of coronary artery disease
Asad Vaisi-Raygani,Hori Ghaneialvar,Zohreh Rahimi,Haidar Tavilani,Tayebeh Pourmotabbed,Ebrahim Shakiba,Aliakbar Vaisi-Raygani,Amir Kiani,Mahdi Aminian,Reza Alibakhshi,Cynthia F. Bartels +10 more
TL;DR: It is indicated that PON1-Arg-192 allele can be important independent risk factor of CAD in a west population of Iran, with carriers of Pon1- Arg-192 having an increased frequency of three-vessel disease and also having a distinct plasma lipids profile.
Journal ArticleDOI
Mutation analysis of PAH gene in patients with PKU in western Iran and its association with polymorphisms: identification of four novel mutations
TL;DR: The present study showed that there is a distinct difference in the characteristics of PAH mutations between the Kermanshah province and other parts of Iran, suggesting that KermANShah may have a unique population distribution ofPAH gene mutations.
Journal Article
Mutation Analysis of CFTR Gene in 70 Iranian Cystic Fibrosis Patients
Reza Alibakhshi,Mahdi Zamani +1 more
TL;DR: Single strand conformation polymorphism analysis of exons 3, 7, 10, 11 and 17b of the CFTR gene was performed in patients in whom no mutation could be identified on one or both CFTR genes, and only three mutations were found.
Journal ArticleDOI
Detection of SPG20 gene promoter-methylated DNA, as a novel epigenetic biomarker, in plasma for colorectal cancer diagnosis using the MethyLight method.
TL;DR: Results from the present study indicate that the identification of SPG20 promoter-methylated DNA in plasma is a potential diagnostic biomarker for the detection of CRC and demonstrates the importance of spastic paraplegia 20 methylation as a novel noninvasive biomarker.